Clinical Trial Update: A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females [Phase 1]

View source ↗

Summary

This Phase 1 dose-finding trial evaluated subcutaneous trastuzumab (Herceptin) in healthy male volunteers and HER2-positive females with breast cancer, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2016-12-16